 Analysts have provided the following ratings for Esperion Therapeutics NASDAQ:ESPR within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 0 0 0 1 Somewhat Bullish 2 0 0 0 Indifferent 3 0 1 1 Somewhat Bearish 0 0 0 Bearish 0 0 0 1 In the last 3 months, 10 analysts have offered 12-month price targets for Esperion Therapeutics. The company has an average price target of 46.6 with a high of 134.00 and a low of 20.00. 